Sequential changes of dopaminergic receptors in the rat brain after 6- hydroxydopamine lesions of the medial forebrain bundle

Journal of the Neurological Sciences

Volumn 160, Issue 2, 1998, Pages 121-127

  Araki, Tsutomu ^a   Tanji, Hiroaki ^a   Kato, Hiroyuki ^a   Itoyama, Yasuto ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

6 Hydroxydopamine; Dopamine receptors; Dopamine uptake sites; Nigrostriatal pathway; Rats; Receptor autoradiography

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DESIPRAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; EMONAPRIDE; MAZINDOL; OXIDOPAMINE; TRITIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; DEGENERATIVE DISEASE; DOPAMINERGIC SYSTEM; MALE; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADRENERGIC AGENTS; ANIMALS; AUTORADIOGRAPHY; BENZAMIDES; BRAIN DISEASES; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; MALE; MAZINDOL; MEDIAL FOREBRAIN BUNDLE; OXIDOPAMINE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; TIME FACTORS;

EID: 0032497630     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00248-2     Document Type: Article

References (40)

1. 3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain. Eur J Pharmacol. 146:1988;113-120.
2. Araki T., Kato H., Kogure K., Kanai Y. Long-term changes in gerbil brain neurotransmitter receptors following transient cerebral ischaemia. Br J Pharmacol. 107:1992;437-442.
3. Araki T., Kato H., Shuto K., Fujiwara T., Itoyama Y. Effect of aging on dopaminergic receptors and uptake sites in the rat brain studied by receptor autoradiography. J Neurol Sci. 148:1997;131-137.
4. Ariano M.A., Stromski C.J., Smyk-Randall E.M., Sibley D.R. D2 dopamine receptor localization on striatonigral neurons. Neurosci Lett. 144:1992;215-220.
5. Berger K., Przedborski S., Cadet J.L. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injections in rats. Brain Res Bull. 26:1991;301-307.
6. Buonamici M., Caccia C., Caepentieri M., Pegrass L., Rossi A.C., Dichiara G. D-1 supersensitivity in the rat striatum after unilateral 6-hydroxy-dopamine lesions. Eur J Pharmacol. 126:1986;347-348.
7. 3H]neurotensin binding by unilateral intrastriatal 6-hydroxydopamine injections: evidence from a receptor autoradiographic study. Brain Res. 564:1991;37-44.
8. Chritin M., Feuerstein C., Savasta M. Time-course of changes in striatal levels of DA uptake sites, DA D2 receptor and preproenkephalin mRNAs after nigrostriatal dopaminergic denervation in the rat. Mol Brain Res. 19:1993;318-322.
9. 1 dopamine receptor. The search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its function implications. Synapse. 1:1987;347-388.
10. 3H]SCH23390. Eur J Pharmacol. 108:1985;323-325.
11. Dawson T.M., Dawson V.L., Gage F.H., Fisher L.J., Hunt M.A., Wamsley J.K. Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra. Exp Neurol. 111:1991;282-292.
12. Fearnley J.M., Lee A.J. Ageing and Parkinson's disease: substantia nigra regional specificity. Brain. 114:1991;2283-2301.
13. 3H]sulpride. Eur J Pharmacol. 138:1987;61-68.
14. Gingrich J.A., Caron M.G. Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci. 16:1993;299-321.
15. 3H]mazindol autoradiography. J Neurosci. 5:1985;1513-1521.
16. Kaakkola S., Teräväinen H. Animal models of Parkinsonism. Pharmacol Toxiol. 67:1990;95-100.
17. Kebabian J.W., Calne D.B. Multiple receptors for dopamine. Nature. 277:1979;93-96.
18. König JFR, Flippel RA. The Rat brain: A stereotaxic atlas of the forebrain and ower parts of the brain stem, Baltimore, Williams and Wilkins, 1963.
19. 3H]-SCH 23390 binding in the rat striatum: similarities to Parkinson's disease. Br J Pharmacol. 87(Suppl.):1986;161P.
20. McGeer P.L., Itagaki S., Akiyama H., McGeer E.G. Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol. 24:1988;574-576.
21. Porceddu M.L., Giorgi O., DeMontis G., Mele S., Cocco L., Ongini E., Biggio G. 6-Hydroxydopamine neurons: differential effect on nigral andstriatal D-1 dopamine receptors. Life Sci. 41:1987;697-706.
22. Pritzel M., Sarter M., Morgan S., Huston J.P. Interhemispheric nigrostriatal projections in the rat: Bifurcating nigral projections and loci of crossing in the Diencephalon. Brain Res Bull. 10:1983;385-390.
23. 2 receptors and uptake sites: A quantitative autoradiographic study. J Neurochem. 57:1991;1951-1961.
24. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togasaki D.M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 67:1995;631-647.
25. Pycock C.J. Turning behavior in animals. Neuroscience. 5:1980;461-514.
26. 2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hibridization and iontophoresis. Neuroscience. 57:1993;635-648.
27. Rogue P., Hanauer A., Zwiller J., Malviya A.N., Vincendon G. Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment. Eur J Pharmacol. 207:1991;165-168.
28. 3H]SCH 23390. Brain Res. 151:1986;291-301.
29. Savasta M., Dobois A., Feuerstein C., Benavides J., Scatton B. Localization of D1 receptors in the rat brain by quantitative autoradiography: effect of dopaminergic denervation. Biogenic Amines. 4:1987;419-429.
30. Sibley F.G., Monsma F.J. Molecular biology of dopamine receptors. Trends Pharmacol Sci. 131:1991;61-69.
31. Sokoloff P., Schwartz J.-C. Novel dopamine receptors half a decade later. Trends Pharmacol Sci. 16:1995;270-275.
32. Spano P.F., Govoni S., Trabucchi M. Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv Biochem Phychopharmacol. 29:1978;155-165.
33. 2 receptor mRNA in rat brain. J Mol Neurosci. 2:1990;155-161.
34. Strange P.G. New insights into dopamine receptors in the central nervous system. Neurochem Int. 22:1993;223-236.
35. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull. 9:1982;321-353.
36. Ungerstedt U. 6-Hydroxydopamine induced degeneration of central monoamine neurons. Eur J Pharmacol. 5:1968;107-110.
37. Ungerstedt U., Arbuthnott G. Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:1970;485-493.
38. 3H]-YM01951-2: A ligand for labelling dopamine D-2 receptors. Life Sci 1990;47:151-155.
39. Venero J.L., Revuelta M., Cano J., Machado A. Time course changes in the dopaminergic nigrostriatal system following transection of the medial forebrain bundle: Detection of oxidatively modified proteins in substantia nigra. J Neurochem. 68:1997;2458-2468.
40. Weiner WJ, Lang AE. Movement disorders: A comprehensive survey, New York: Futura, 1989.